Sleep Duration and Framingham´s Cardiovascular Risk Score: Results from the Hoveyzeh Cohort Study (HCS)

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2023 Nov 21

PMID 37986150

Authors

Bahman Cheraghian

Habib Heybar

Nader Saki

Maedeh Raeisizadeh

Seyed Jalal Hashemi

Saeid Bitaraf

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular diseases (CVDs) are the leading causes of global deaths. So, it is necessary to know the possible risk factors for each region. We aimed to assess the relationship between the risk of CVDs and sleep duration in the Iranian Arab population.

Methods: In this cross-sectional study, data from 8362 participants aged between 35 and 70 from the Hoveyzeh Cohort Study enrollment phase between 2016 and 2018 was analyzed. This study evaluated the association between ten-year CVD risk using the Framingham risk score and sleep duration. Self-reported sleep duration was categorized as short duration (equal to or less than 5 h), standard duration (6-8 h), or prolonged duration (equal to or greater than 9 h). Multivariable logistic regression to adjust for conventional CVD risks was used.

Results: Among the assessed participants, 4892 (58.50%) were female, and the mean age was 47.93 (9.01). The average sleep duration was 7.59 (1.56) hours. The low, intermediate-to-high, and high CVD risk individuals were 6461 (77.27%), 1185 (14.17%), and 716 (8.56%), respectively. There was a significant relationship between prolonged sleep duration and lower odds of intermediate-to-high CVD risk in males (OR 0.66, 95% CI: 0.49-0.87, P-value: 0.004).

Conclusion: The results of our study showed that longer sleep duration has a protective association with the intermediate to high risk of cardiovascular diseases in males. However, long and short sleep durations have no significant relationship with females' risk of cardiovascular disease.

References

Cheraghian B, Hashemi S, Hosseini S, Poustchi H, Rahimi Z, Sarvandian S . Cohort profile: The Hoveyzeh Cohort Study (HCS): A prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran. Med J Islam Repub Iran. 2021; 34:141. PMC: 7787022. DOI: 10.34171/mjiri.34.141. View

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

Grandner M, Chakravorty S, Perlis M, Oliver L, Gurubhagavatula I . Habitual sleep duration associated with self-reported and objectively determined cardiometabolic risk factors. Sleep Med. 2013; 15(1):42-50. PMC: 3947242. DOI: 10.1016/j.sleep.2013.09.012. View

Qureshi A, Giles W, Croft J, Bliwise D . Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology. 1997; 48(4):904-11. DOI: 10.1212/wnl.48.4.904. View

Im E, Kim G . Relationship between sleep duration and Framingham cardiovascular risk score and prevalence of cardiovascular disease in Koreans. Medicine (Baltimore). 2017; 96(37):e7744. PMC: 5604628. DOI: 10.1097/MD.0000000000007744. View

Anujuo K, Stronks K, Snijder M, Jean-Louis G, Rutters F, van den Born B . Relationship between short sleep duration and cardiovascular risk factors in a multi-ethnic cohort - the helius study. Sleep Med. 2015; 16(12):1482-8. DOI: 10.1016/j.sleep.2015.08.014. View

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A, Hekmatdoost A . Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. Am J Epidemiol. 2017; 187(4):647-655. PMC: 6279089. DOI: 10.1093/aje/kwx314. View

Holliday E, Magee C, Kritharides L, Banks E, Attia J . Short sleep duration is associated with risk of future diabetes but not cardiovascular disease: a prospective study and meta-analysis. PLoS One. 2013; 8(11):e82305. PMC: 3840027. DOI: 10.1371/journal.pone.0082305. View

van Mill J, Hoogendijk W, Vogelzangs N, van Dyck R, Penninx B . Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010; 71(3):239-46. DOI: 10.4088/JCP.09m05218gry. View

10.

Mokhtari M, Khalil D, Farzadfar F, Daroudi R, Asadi-Lari M . The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran. Med J Islam Repub Iran. 2022; 36:73. PMC: 9448466. DOI: 10.47176/mjiri.36.73. View

11.

Khani M, Najafian J, Taheri M, Akhavan-Tabib A, Hosseini S . Association between sleep duration and electrocardiographic ischemic changes in middle-aged population: Isfahan Healthy Heart Program. ARYA Atheroscler. 2018; 14(3):115-121. PMC: 6191569. DOI: 10.22122/arya.v14i3.1656. View

12.

Saki N, Karandish M, Cheraghian B, Heybar H, Hashemi S, Azhdari M . Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: Baseline data from Hoveyzeh Cohort Study. BMC Cardiovasc Disord. 2022; 22(1):309. PMC: 9270737. DOI: 10.1186/s12872-022-02746-y. View

13.

Coronado F, Melvin S, Bell R, Zhao G . Global Responses to Prevent, Manage, and Control Cardiovascular Diseases. Prev Chronic Dis. 2022; 19:E84. PMC: 9746707. DOI: 10.5888/pcd19.220347. View

14.

Hashemi S, Karandish M, Cheraghian B, Azhdari M . Prevalence of prediabetes and associated factors in southwest iran: results from Hoveyzeh cohort study. BMC Endocr Disord. 2022; 22(1):72. PMC: 8933994. DOI: 10.1186/s12902-022-00990-z. View

15.

Liu J, Yuen J, Kang S . Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study. Nutr Metab Cardiovasc Dis. 2014; 24(6):600-5. DOI: 10.1016/j.numecd.2013.12.012. View

16.

Wang S, Li Z, Wang X, Guo S, Sun Y, Li G . Associations between sleep duration and cardiovascular diseases: A meta-review and meta-analysis of observational and Mendelian randomization studies. Front Cardiovasc Med. 2022; 9:930000. PMC: 9403140. DOI: 10.3389/fcvm.2022.930000. View

17.

Henst R, Pienaar P, Roden L, Rae D . The effects of sleep extension on cardiometabolic risk factors: A systematic review. J Sleep Res. 2019; 28(6):e12865. DOI: 10.1111/jsr.12865. View

18.

Cakir H, Gunes A, Er F, Cakir H, Karagoz A, Yilmaz F . Evaluating the relationship of sleep quality and sleep duration with Framingham coronary heart disease risk score. Chronobiol Int. 2022; 39(5):636-643. DOI: 10.1080/07420528.2021.2018453. View

19.

Krishnan V, Collop N . Gender differences in sleep disorders. Curr Opin Pulm Med. 2006; 12(6):383-9. DOI: 10.1097/01.mcp.0000245705.69440.6a. View

20.

Yousefi M, Dastan I, Alinezhad F, Ranjbar M, Hamelmann C, Ostovar A . Prevention and control of non-communicable diseases in iran: the case for Investment. BMC Public Health. 2022; 22(1):1248. PMC: 9229124. DOI: 10.1186/s12889-022-13615-w. View